Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
ESPERITE N.V. announces important recurrent financial improvements from Laboratory transfer and cost reduction program Galaxy 1.2 Millions euro saving per...
-
ESPERITE N.V. is confident in its future and successes Esperite comments on FD article Zutphen, The Netherlands - 31 January 2016 On 30...
-
ESPERITE N.V. is confident in its future and successes Esperite comments on FD article Zutphen, The Netherlands - 31 January...
-
ESPERITE (ESP) Trading update Q1-2016 Genoma grows and widens its footprint on the market. CryoSave newly configured, launches new products for Q2 2016.Effectiveness of cost...
-
Genoma on a sharp growth for its strategic expansionCryoSave fell short due to major changes in workflowEsperite now with stronger markets positions, but late on schedule. Zutphen, the...
-
Zutphen, the Netherlands - 28 April 2016 Esperite N.V. announces that it has convened its Annual General Meeting of Shareholders ("AGM") to be held on Thursday 9 June 2016 at 14:00 hours CET at...
-
Geneva, Switzerland - 22 April 2016 We, Genoma SA, (DAVID), Genomics company specialised in Prenatal and Oncology DNA analysis for early detection and follow-up of genetically caused diseases, have...
-
Zutphen, The Netherlands - 26 February 2016 ESPERITE N.V. (Euronext: ESP, 'ESPERITE', or 'the Group') announces that following the amendment of the Dutch Financial Supervision Act (FSA) as a...
-
Genoma continues its intercontinental expansion through a partnership with Intercare, a South African healthcare leader. Geneva, Switzerland- 9th February 2016 Genoma is now present in the South...
-
Genoma continues its intercontinental expansion through a partnership with Intercare, a South African healthcare leader. Geneva, Switzerland- 9th February 2016 Genoma is now present in the South...